Overexpressing CuZnSOD targeting the PVN could reduce oxide and caused a surge in AP-1 activity, and expression of a dominant-negative inhibitor of AP-1 activity in the PVN prevented 2K1C-evoked hypertension (Figure 5). Here, FOS is linked to Hypertension.